Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|June 2, 2017
- Pharmaceutical Technology-06-02-2017
- Volume 41
- Issue 6
Paperless Recorder Shortens Sampling Intervals
The SMARTDAC+ GX series panel-mount type paperless recorder from Yokogawa Electric Corporation comes with new functions, including sampling intervals as short as one millisecond and the control and monitoring of up to 20 loops.
The SMARTDAC+ GX series panel-mount type paperless recorder from Yokogawa Electric Corporation comes with new functions, including sampling intervals as short as one millisecond and the control and monitoring of up to 20 loops. The recorder includes an analog input module for high-speed sampling. The system can sample data at intervals as brief as one millisecond and is suitable for high-performance applications.
The combination of the continuous recording function of the SMARTDAC+ and proportional integral derivative (PID) control module allows for critical process data to be controlled and recorded in one system. The SMARTDAC+ can control, monitor, and record up to 20 loops. Each PID control module comes with two analog inputs, two analog outputs, eight digital inputs, and eight digital outputs. The recorder also includes a four-wire resistance temperature detector for precise temperature measurements.
Articles in this issue
over 9 years ago
Control Box Connects Lab Sensors and Pumpsover 9 years ago
Planetary Dispersers with PLC Recipe Controlsover 9 years ago
Sterilizer Uses Pulsed Light Technologyover 9 years ago
Boosting Bioproduction Workflows with Automation Technologiesover 9 years ago
Decoding Serialization Regulationsover 9 years ago
Synchronizing Anticounterfeiting Effortsover 9 years ago
New and Updated Laboratory Equipment Optimize Efficiencyover 9 years ago
Understanding Dissolution Testingover 9 years ago
Particle Size Reduction for Investigational New DrugsRelated to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.